binder

(redirected from Phosphate binder)
Also found in: Dictionary, Thesaurus, Medical, Legal, Encyclopedia, Wikipedia.

Binder

An amount of money paid to indicate good faith in a transaction before the transaction is completed.

Earnest Money

A small amount of money that a seller requires a potential buyer to deposit before a transaction is completed. Earnest money ensures that the potential buyer is serious about the transaction and will be likely to complete it when the time comes. If the buyer subsequently withdraws from the deal, he/she usually forfeits the earnest money. It is common in real estate and securities (where it is usually called a good faith deposit). Earnest money reduces the risk to the seller. It is also called a binder.

binder

(1) Money given as earnest money for an oral contract to purchase real estate, to bind the parties until such time as they can complete the necessary written contract. (2) A written instrument giving immediate casualty coverage for property, even though the insured may not have paid a premium or received a policy.(3) A temporary contract of title insurance in which the insurer agrees to issue a final policy if certain exceptions, such as prior mortgage liens, are removed at or before closing.

References in periodicals archive ?
Thus, it is possible to find bacteria flora associated with phosphorus metabolism with the model of using phosphate binder. In this study, we took advantage of the model of 'phosphate-binder therapy' to perform a longitudinal study, to observe the change of microflora.
* Avoid calcium-based phosphate binders in patients with known vascular calcifications.
The use of phosphate binders in order to decrease phosphate levels diminishes the incidence of metastatic calcifications (12, 13).
dos Reis et al., "Disturbances of Wnt/[beta]-catenin pathway and energy metabolism in early CKD: effect of phosphate binders," Nephrology, Dialysis, Transplantation, vol.
Rodriguez et al., "The effect of phosphate binders, calcium and lanthanum carbonate on FGF23 levels in chronic kidney disease patients," Clinical Nephrology, vol.
Education regarding the importance of phosphate binders and compliance with medication was provided by dialysis nurses and patient participation was tracked on a "Tally board" within each unit.
Amount of Fluid Ingested with Phosphate Binders in Hemodialysis Dependent Chronic Kidney Disease (HDD-CKD) Patients (Abstract).
Ilypsa's lead drug candidate, ILY101, is a phosphate binder for the treatment of hyperphosphatemia in CKD (chronic kidney disease) patients on hemodialysis.
Renvela is being developed as a next generation phosphate binder to replace Renagel (sevelamer hydrochloride), the most-prescribed phosphate binder in the United States.
Fosrenol(R) is a non-aluminium, non-calciumbased phosphate binder and is sold around the world in 15 countries, including the US, Taiwan, Korea, Germany Sweden, Denmark, Austria and Ireland.
"We are very encouraged by the outcome of our Phase 1 study, and believe that ILY101 has the potential to offer an improved treatment option to patients who require chronic phosphate binder therapy."